|
End-of-day quote
Korea S.E.
13/11/2026
|
5-day change | 1st Jan Change | ||
| 12,030.00 KRW | -0.91% |
|
-7.53% | -76.73% |
| Market Cap | 157B 118M 107M 98.74M 89.09M 168M 11.11B 174M 1.19B 470M 5.93B 442M 433M 18.83B | P/E 2024 |
-2.95x | P/E 2025 | 28.3x |
|---|---|---|---|---|---|
| Enterprise Value | 251B 187M 170M 157M 142M 267M 17.67B 277M 1.89B 748M 9.44B 703M 689M 29.97B | EV / Sales 2024 |
2.48x | EV / Sales 2025 | 3.64x |
| Free-Float |
58.13% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -0.91% | ||
| 1 week | -7.53% | ||
| Current month | -3.06% | ||
| 1 month | -10.95% | ||
| 3 months | -28.31% | ||
| 6 months | -81.55% | ||
| Current year | -76.73% |
| 1 week | 11,960 |  | 13,240 |
| 1 month | 11,960 | | 13,890 |
| Current year | 11,960 | | 72,700 |
| 1 year | 11,960 | | 72,700 |
| 3 years | 11,960 | | 72,700 |
| 5 years | 11,960 | | 72,700 |
| 10 years | 11,000 | | 127,600 |
| Manager | Title | Age | Since |
|---|---|---|---|
Seon-Jin Kim
CEO | Chief Executive Officer | 65 | 28/03/2023 |
Yeong-U Jo
PRN | Corporate Officer/Principal | 59 | 01/07/2016 |
Jong-Won Kim
AUD | Comptroller/Controller/Auditor | 67 | 28/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Yeong-U Jo
BRD | Director/Board Member | 59 | 25/03/2021 |
Seon-Jin Kim
BRD | Director/Board Member | 65 | 28/03/2023 |
Seok-Jung Yun
BRD | Director/Board Member | 59 | 28/03/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.91% | -7.53% | -67.40% | -54.69% | 119M | |
| +1.26% | +6.61% | +41.12% | +135.59% | 1,271B | |
| +0.79% | +3.45% | +46.35% | +93.56% | 683B | |
| +0.20% | +1.28% | +27.01% | +112.80% | 520B | |
| -0.44% | +3.32% | +39.36% | +70.94% | 389B | |
| +0.55% | +0.70% | +59.00% | +44.20% | 362B | |
| -0.12% | -0.04% | +28.04% | +59.86% | 304B | |
| +0.37% | -0.43% | +3.43% | +38.57% | 286B | |
| -0.30% | +1.14% | +38.59% | +74.61% | 253B | |
| +0.08% | +0.71% | +34.25% | +124.32% | 208B | |
| Average | +0.11% | +1.22% | +24.98% | +69.98% | 428B | |
| Weighted average by Cap. | +0.51% | +2.67% | +37.66% | +96.46% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 161B 121M 109M 101M 91.3M 172M 11.38B 178M 1.22B 482M 6.08B 453M 443M 19.3B | 209B 156M 142M 131M 118M 223M 14.74B 231M 1.57B 624M 7.87B 587M 574M 24.99B |
| Net income | -93.09B -69.63M -63.1M -58.37M -52.66M -99.24M -6.57B -103M -701M -278M -3.51B -261M -256M -11.13B | 24.96B 18.67M 16.92M 15.65M 14.12M 26.61M 1.76B 27.55M 188M 74.55M 940M 70.07M 68.58M 2.99B |
| Net Debt | 114B 85.35M 77.35M 71.54M 64.55M 122M 8.05B 126M 859M 341M 4.3B 320M 314M 13.65B | 93.09B 69.64M 63.11M 58.37M 52.67M 99.25M 6.57B 103M 701M 278M 3.51B 261M 256M 11.13B |
Employees
440
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | ₩12,030.00 | -0.91% | 49,928 |
| 12/11/26 | ₩12,140.00 | -2.88% | 71,697 |
| 11/11/26 | ₩12,500.00 | -0.16% | 60,424 |
| 10/11/26 | ₩12,520.00 | +0.56% | 56,537 |
| 09/11/26 | ₩12,450.00 | -0.80% | 100,741 |
- Stock Market
- Stocks
- A102940 Stock
Select your edition
All financial news and data tailored to specific country editions
